INS and Hyperglycemia: Additionally, CSQ treatment demonstrated an impressive potential activity toward streptozotocin (STZ)-induced toxicity and safeguards the pancreas from oxidative stress-mediated hyperglycemia, which results in the renewal of the pancreatic islets and may increase exudation of insulin in STZ-induced diabetes (23).